Methodological Insights from the ERASe Trial
- PMID: 39315870
- DOI: 10.1056/EVIDe2400296
Methodological Insights from the ERASe Trial
Comment on
-
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.NEJM Evid. 2024 Oct;3(10):EVIDoa2400147. doi: 10.1056/EVIDoa2400147. Epub 2024 Sep 1. NEJM Evid. 2024. PMID: 39217453 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources